The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
One-year overall survival (OS) and biomarker correlates from a phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM).
 
Rahima Jamal
Honoraria - Bristol-Myers Squibb; Merck; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MedImmune (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Leon Van Kempen
No Relationships to Disclose
 
Pamela Thebault
No Relationships to Disclose
 
Karl Belanger
No Relationships to Disclose
 
Jennifer Elisabeth Friedmann
Honoraria - Pfizer
 
Jean-Pierre M. Ayoub
Honoraria - Novartis; Sanofi
Consulting or Advisory Role - NanoString Technologies; Novartis; Roche
Speakers' Bureau - AstraZeneca; Eisai; Roche
Research Funding - Abbvie; Bayer; Celgene; Novartis; Tesaro
 
Eftihia Cocolakis
No Relationships to Disclose
 
Shirin Kazemi
No Relationships to Disclose
 
Jeanne Dionne
No Relationships to Disclose
 
Caroline Lambert
No Relationships to Disclose
 
HB Le
No Relationships to Disclose
 
Cecile Grange
No Relationships to Disclose
 
Jean-Francois Cailhier
No Relationships to Disclose
 
Alan Spatz
Honoraria - Merck
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Roche Pharma AG
Research Funding - Bristol-Myers Squibb (Inst)
 
Rejean Lapointe
Research Funding - Bristol-Myers Squibb (Inst); Folia Biotech (Inst); Merck Sharp & Dohme (Inst)
 
Wilson H. Miller
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis; Roche Pharma AG